VisionCare Eye Clinic — Risk Assessment & Mitigation

A structured risk assessment and the mitigation measures covering clinical, market, financial, regulatory and operational risks.

VisionCare Eye Clinic Business PlanSection 9 › Risk Assessment & Mitigation

Section 9 · Business Plan

Risk Assessment & Mitigation

A structured risk assessment and the mitigation measures covering clinical, market, financial, regulatory and operational risks.

A disciplined approach to risk identification and mitigation is
central to both operational resilience and investor confidence. The
risks set out below were identified through a structured workshop
involving the management team and external advisors, then rated on a
5-point scale for likelihood (L) and impact (I) to produce a composite
risk score.

9.1 SWOT Analysis

Figure 10
Figure 10: SWOT analysis — VisionCare Eye Clinic.

9.2 Risk Register

Risk Likelihood Impact Score Mitigation
NHI policy implementation disrupts private-scheme market 2 4 8 Maintain dual-compatible business model; ensure accreditation-readiness for NHI contracting; diversify revenue across cash-pay and corporate channels.
Delayed HPCSA practice registration 3 3 9 Submit all applications in Month 0 with buffer; engage an experienced regulatory advisor; maintain weekly status tracking.
Failure to secure scheme preferred-provider contracts 2 5 10 CEO directly owns scheme contracting; engage specialist healthcare consultant; commence applications pre-launch; build out-of-network cash-pay fallback.
Key clinician departure (ophthalmologist) 2 4 8 Multi-year service agreement with equity participation; identified backup clinician network; documented clinical SOPs allow rapid replacement.
Equipment downtime / major breakdown 2 3 6 Five-year service contracts with 24-hour response SLAs; critical-spares inventory; equipment-breakdown insurance.
Patient volume below plan 3 4 12 Conservative demand assumptions in Base Case; active pipeline of corporate and scheme contracts; flexible staffing model with contracted professionals.
Tariff compression by medical schemes 3 3 9 Diversify across 6+ schemes; strong optical retail margin buffer; efficiency programme to reduce cost per encounter.
ZAR/USD exchange-rate movement raises imported equipment cost 4 3 12 Forward cover on large equipment orders above R500k; phase procurement; consider hedged lease/finance on large-ticket items.
Cyber-security or data-breach event 2 5 10 POPIA-compliant EMR with encryption at rest/transit; cyber-insurance policy; annual penetration testing; staff awareness training.
Medical malpractice claim 2 4 8 Comprehensive medical indemnity; documented clinical protocols; robust consent processes; monthly morbidity review.
Construction delay on premises fit-out 3 3 9 Fixed-price lump-sum contractor; penalty clauses for late completion; weekly project-manager oversight.
Electricity supply (loadshedding) 4 3 12 Full back-up power (UPS for clinical equipment + diesel generator); solar + battery investigation for Y2.
Economic recession reduces elective spend 3 3 9 Scheme-covered core services insulated from discretionary spend; tiered pricing enables trade-down retention; cost flex on marketing spend.
Competitor opens adjacent facility 3 3 9 First-mover scheme-contract coverage creates switching cost; continuous reinvestment in patient experience; loyalty programme.
Key supplier insolvency (lens laboratory) 1 3 3 Dual-sourced lens-lab relationships; minimum safety stock of high-volume SKUs.
Medical-scheme claim reversal / audit recoupment 3 2 6 Robust clinical documentation; pre-authorisation discipline; dedicated billing coordinator; internal monthly billing audit.

9.3 Insurance Programme

A comprehensive insurance programme transfers specific high-impact
risks to third-party carriers. The annual insurance premium is modelled
at approximately R280,000 in Year 1, rising proportionally with turnover
and surgical volume:

Policy Coverage Summary
Medical malpractice / professional indemnity Per-practitioner and practice-level cover with limits of R20M per claim / R40M aggregate
Public liability R20M per occurrence for patient or visitor injury on premises
Asset / equipment insurance All-risk replacement cover including electronic equipment extension
Business interruption 12-month indemnity period covering fixed costs and loss of profit
Cyber liability Coverage for data-breach response, regulatory fines, and third-party claims
Directors & officers (D&O) Coverage for directors’ personal liability
Employer liability / COIDA top-up Supplementary cover above statutory COIDA limits
Key-person life / disability On lead clinician and CEO, sum insured linked to projected profit impact

9.4 Scenario Modelling

The financial model supports three scenarios:

  • Base Case: as presented in Section 10 — patient
    volume ramp, pricing escalation, and cost assumptions aligned with
    industry benchmarks. EBITDA break-even at Month 20; Year-5 EBITDA of
    R15.46M.
  • Downside Case: 15% reduction in patient volume,
    5% compression in scheme tariffs, and 10% overshoot on operating costs.
    EBITDA break-even delayed to Month 28; Year-5 EBITDA of R8.2M. Even in
    this scenario, the debt service coverage ratio remains above 1.3× from
    Year 3 onward.
  • Upside Case: 10% higher volume, 2% higher
    tariffs, corporate contracts signing at double the Base Case pace.
    EBITDA break-even at Month 16; Year-5 EBITDA of R22.1M; IRR of
    41%+.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of VisionCare Eye Clinic (Pty) Ltd.